|4Feb 17, 7:21 PM ET

Chaubey Alka 4

4 · Bionano Genomics, Inc. · Filed Feb 17, 2023

Insider Transaction Report

Form 4
Period: 2023-02-15
Chaubey Alka
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Common Stock

    2023-02-15+120,000124,794 total
  • Award

    Stock Option (Right to Buy)

    2023-02-15+560,000560,000 total
    Exercise: $1.63Exp: 2033-02-14Common Stock (560,000 underlying)
Footnotes (3)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
  • [F2]Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022.
  • [F3]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION